Randall Kaye
Executive Vice President & CMO · Longboard Pharmaceuticals, Inc.
IndividualSelling only3 10b5-1 trades
- 2024
- Dec 2, 2024
- 4
Other insiders active in the same sector
No other insider has filed at Randall Kaye's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $69.43M in VOR purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Randall Kaye?
Randall Kaye is a corporate insider, tracked as Executive Vice President & CMO of Longboard Pharmaceuticals, Inc. (LBPH). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Randall Kaye last file a Form 4?
The most recent primary Form 4 on record is dated 2 December 2024, one of 4 filings going back to 2024.
Has Randall Kaye been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($984K) across all tracked filings.
